epidepride has been researched along with Huntington Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, DN; Greenberg, CR; Hobson, D; Leslie, WD | 2 |
| Angelberger, P; Asenbaum, S; Brücke, T; Deecke, L; Kornhuber, J; Pirker, W; Podreka, I; Wenger, S | 1 |
3 other study(ies) available for epidepride and Huntington Disease
| Article | Year |
|---|---|
Comparison of iodine-123-epidepride and iodine-123-IBZM for dopamine D2 receptor imaging.
Topics: Adult; Benzamides; Brain; Brain Chemistry; Contrast Media; Dopamine Antagonists; Humans; Huntington Disease; Iodine Radioisotopes; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Risk Factors; Tomography, Emission-Computed, Single-Photon | 1996 |
Iodine-123-epidepride-SPECT: studies in Parkinson's disease, multiple system atrophy and Huntington's disease.
Topics: Adult; Age Factors; Aged; Benzamides; Brain; Case-Control Studies; Contrast Media; Diagnosis, Differential; Evaluation Studies as Topic; Female; Humans; Huntington Disease; Iodine Radioisotopes; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1997 |
Clinical deficits in Huntington disease correlate with reduced striatal uptake on iodine-123 epidepride single-photon emission tomography.
Topics: Adult; Benzamides; Brain; Case-Control Studies; Contrast Media; Corpus Striatum; Humans; Huntington Disease; Image Processing, Computer-Assisted; Iodine Radioisotopes; Middle Aged; Pyrrolidines; Receptors, Dopamine D2; Tomography, Emission-Computed, Single-Photon | 1999 |